XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -4.23%45.33M | 18.97%104.54M | 18.82%47.34M | 14.78%87.87M | 25.05%39.84M | 19.15%76.55M | 14.67%31.86M | 10.50%64.25M | --27.78M | 20.36%58.15M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -32.90%-4.27M | -113.69%-5.99M | -441.82%-3.21M | -88.89%-2.81M | 0.17%-593K | 93.90%-1.49M | 95.42%-594K | -11.52%-24.36M | ---12.98M | -73.02%-21.84M |
Attributable subsidiary (profit) loss | -97.67%6K | -152.86%-1.06M | -74.80%258K | -33.10%2.01M | -39.01%1.02M | --3.01M | --1.68M | ---- | ---- | ---- |
Impairment and provisions: | -41.91%5.02M | ---- | 420.79%8.64M | ---- | -155.86%-2.69M | -130.01%-1.42M | -15.39%4.82M | -23.80%4.74M | --5.7M | -6.51%6.22M |
-Impairment of trade receivables (reversal) | -41.91%5.02M | ---- | 420.79%8.64M | ---- | -155.86%-2.69M | -130.01%-1.42M | -15.39%4.82M | -23.80%4.74M | --5.7M | -6.51%6.22M |
Revaluation surplus: | 1,087.05%10.52M | 765.03%20.29M | -433.13%-1.07M | 33.14%-3.05M | 125.34%320K | -1,178.15%-4.56M | -349.47%-1.26M | 82.25%-357K | ---281K | 0.00%-2.01M |
-Fair value of investment properties (increase) | 1,087.05%10.52M | 765.03%20.29M | -433.13%-1.07M | 33.14%-3.05M | 125.34%320K | -1,178.15%-4.56M | -349.47%-1.26M | 82.25%-357K | ---281K | 0.00%-2.01M |
Asset sale loss (gain): | 1,450.00%31K | -233.58%-1.25M | -98.87%2K | 3,239.29%935K | 8,750.00%177K | 55.56%28K | -50.00%2K | -64.00%18K | --4K | 100.63%50K |
-Loss (gain) from sale of subsidiary company | ---- | ---1.29M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | 1,450.00%31K | -95.83%39K | -98.87%2K | 3,239.29%935K | 8,750.00%177K | 55.56%28K | -50.00%2K | -64.00%18K | --4K | 100.63%50K |
Depreciation and amortization: | -0.39%13.71M | 35.75%27.45M | 33.74%13.76M | 54.99%20.22M | 73.36%10.29M | 39.46%13.05M | 73.79%5.94M | 29.87%9.36M | --3.42M | 62.35%7.21M |
-Amortization of intangible assets | -6.06%62K | -50.00%86K | 26.92%66K | 290.91%172K | 205.88%52K | 2,100.00%44K | --17K | --2K | ---- | ---- |
Financial expense | -13.46%6.84M | 26.74%15.18M | 83.69%7.9M | 209.99%11.98M | 186.10%4.3M | -83.92%3.86M | -87.41%1.5M | 3.99%24.03M | --11.95M | 58.90%23.11M |
Exchange Loss (gain) | 71.90%-1.57M | ---- | ---5.58M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | 11.14%75.62M | 35.84%159.15M | 29.19%68.04M | 31.59%117.16M | 19.85%52.67M | 14.61%89.03M | 23.49%43.94M | 9.61%77.69M | --35.58M | 37.87%70.88M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 44.44%-5K | -110.61%-7K | -125.71%-9K | 414.29%66K | -31.37%35K | -124.14%-21K | 342.86%51K | 89.13%87K | ---21K | -16.36%46K |
Accounts receivable (increase)decrease | -25.31%-143.93M | -141.16%-153.5M | -2,098.76%-114.86M | -284.35%-63.65M | 76.09%-5.22M | -37,738.64%-16.56M | -854.12%-21.85M | 100.11%44K | --2.9M | -382.79%-41.18M |
Accounts payable increase (decrease) | 5.65%61.55M | 1,809.98%134.41M | 976.98%58.26M | 187.25%7.04M | -191.87%-6.64M | -122.50%-8.07M | -113.13%-2.28M | 36.42%35.84M | --17.34M | 11.63%26.27M |
prepayments (increase)decrease | -3,719.74%-5.81M | -68.82%1.33M | -101.75%-152K | 229.42%4.27M | 244.38%8.68M | 45.61%-3.3M | 0.41%-6.01M | 28.76%-6.07M | ---6.04M | -593.86%-8.52M |
Special items for working capital changes | -12,205.13%-62.39M | 140.68%14.48M | 97.34%-507K | -208.93%-35.59M | -2,179.23%-19.03M | 392.91%32.68M | 8.67%915K | 48.30%6.63M | --842K | 255.59%4.47M |
Cash from business operations | -796.18%-74.97M | 432.12%155.86M | -64.68%10.77M | -68.76%29.29M | 106.33%30.49M | -17.91%93.76M | -70.80%14.78M | 119.77%114.22M | --50.6M | -20.44%51.97M |
Other taxs | -69.03%-18.92M | 5.67%-21.04M | -11.61%-11.19M | 5.05%-22.31M | 28.97%-10.03M | 7.36%-23.5M | 12.84%-14.12M | -275.29%-25.36M | ---16.2M | 28.95%-6.76M |
Net cash from operations | -21,990.35%-93.88M | 1,831.18%134.82M | -102.08%-425K | -90.06%6.98M | 3,013.85%20.46M | -20.92%70.27M | -98.09%657K | 96.53%88.86M | --34.4M | -18.99%45.21M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 32.90%4.27M | 113.69%5.99M | 441.82%3.21M | 88.89%2.81M | -0.17%593K | -93.87%1.49M | -95.39%594K | 11.49%24.23M | --12.89M | 72.15%21.73M |
Dividend received - investment | ---- | --760K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | 3,035.08%35.22M | -3,408.83%-67.97M | ---1.2M | ---1.94M | ---- | ---- | ---- | 263.74%5.71M | --5.71M | -9,081.58%-3.49M |
Sale of fixed assets | 5.71%37K | 221.43%270K | -85.17%35K | 121.05%84K | -29.97%236K | 1,800.00%38K | 5,516.67%337K | -96.72%2K | --6K | -99.30%61K |
Purchase of fixed assets | 67.70%-13.33M | 15.01%-48.46M | -20.89%-41.28M | 6.20%-57.02M | -22.49%-34.15M | 18.66%-60.79M | 40.14%-27.88M | 19.31%-74.73M | ---46.57M | -191.47%-92.62M |
Purchase of intangible assets | -0.22%-448K | -8.81%-568K | 9.88%-447K | -136.20%-522K | -188.37%-496K | 94.13%-221K | 95.21%-172K | ---3.76M | ---3.59M | ---- |
Sale of subsidiaries | ---- | --5.81M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | --6M | --59.48M | ---- | ---- | ---- | ---- | ---- | 0.13%15.13M | --15.09M | --15.11M |
Cash on investment | ---- | ---19.29M | ---1M | ---- | ---- | 67.38%-4.9M | 51.59%-4.9M | 24.89%-15.02M | ---10.12M | ---20M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 309.52%469.38M | ---36.92M | -4,037.17%-224.03M |
Net cash from investment operations | 178.04%31.75M | -13.04%-63.97M | -20.30%-40.68M | 12.11%-56.59M | -5.61%-33.81M | -115.30%-64.39M | 49.58%-32.02M | 238.82%420.93M | ---63.5M | -1,181.14%-303.23M |
Net cash before financing | -51.18%-62.14M | 242.82%70.85M | -207.79%-41.1M | -944.09%-49.61M | 57.42%-13.35M | -98.85%5.88M | -7.77%-31.36M | 297.58%509.79M | ---29.1M | -902.75%-258.02M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 944.57%127.56M | ---- | -70.57%12.21M | ---- | -61.75%41.5M | -32.50%40.5M | -70.34%108.5M | --60M | 143.87%365.8M |
Refund | -45.48%-5M | -77.01%-138.51M | 94.31%-3.44M | -1,152.00%-78.25M | -1,658.42%-60.44M | 99.14%-6.25M | 96.73%-3.44M | -1,409.39%-724.51M | ---105M | 5.88%-48M |
Issuing shares | ---- | ---- | ---- | --194.97M | ---- | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | -73.43%-5.24M | 12.51%-12.11M | 9.22%-3.02M | -3.08%-13.84M | 1.94%-3.33M | 57.27%-13.42M | 79.88%-3.4M | -0.04%-31.42M | ---16.88M | -93.80%-31.41M |
Dividends paid - financing | ---12.75M | ---4.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.00%-200K |
Absorb investment income | ---- | 76.26%2.45M | 76.26%2.45M | --1.39M | --1.39M | ---- | ---- | --5M | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | 88.09%-2.84M | 13.59%-2.62M | -82.57%-23.81M | 53.98%-3.03M | -610.79%-13.04M | ---6.59M | ---1.84M | ---- | ---- |
Other items of the financing business | ---- | ---4.19M | ---- | ---- | ---- | ---- | ---- | --200M | --222.71M | ---- |
Net cash from financing operations | -246.82%-22.99M | -134.90%-32.35M | 89.87%-6.63M | 983.04%92.68M | -343.57%-65.41M | 101.92%8.56M | -83.26%26.85M | -256.82%-444.88M | --160.44M | 246.01%283.68M |
Effect of rate | -71.90%1.57M | -41.64%2.91M | --5.58M | --4.99M | ---- | ---- | ---- | ---- | ---- | ---- |
Net Cash | -78.35%-85.13M | -10.61%38.5M | 39.40%-47.73M | 198.39%43.07M | -1,648.32%-78.76M | -77.76%14.43M | -103.43%-4.51M | 152.95%64.91M | --131.34M | -77.51%25.66M |
Begining period cash | 11.64%397.32M | 15.61%355.91M | 17.60%355.91M | 6.82%307.85M | 5.01%302.64M | 29.07%288.21M | 29.07%288.21M | 12.98%223.3M | --223.3M | 136.67%197.64M |
Cash at the end | 0.00%313.76M | 11.64%397.32M | 40.14%313.76M | 17.60%355.91M | -21.09%223.88M | 5.01%302.64M | -20.00%283.71M | 29.07%288.21M | --354.64M | 12.98%223.3M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | 5.16%303.09M | -20.06%283.71M | 50.30%288.21M | --354.88M | 9.01%191.76M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | 5.16%303.09M | -20.06%283.71M | 50.30%288.21M | --354.88M | 9.01%191.76M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.